Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an...
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an...
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Contacts Investor Contact: investors@guardanthealth.com Media...
Gen Board authorizes $3 billion share repurchase program TEMPE, Ariz. and PRAGUE, May 9, 2024 /PRNewswire/ -- Gen Digital Inc....
AlphaBreak is a Phase 2/3 registrational program for FPI-2265 in patients with metastatic castration-resistant prostate cancer HAMILTON, ON and BOSTON,...
– Company Targets Achieving and Remaining Adjusted EBITDA Positive Moving Forward– CARY, N.C., May 9, 2024 /PRNewswire/ -- Fathom Holdings...
Total Revenues of $100.3 million; up 26% Year-over-Year Cloud Revenues up 47% in 1Q24; driven by customer usage Customers with...
--Q1 Net Sales Within Guidance Range, Gross Margin and Adjusted EBITDA Above Expectations; New CEO Appointed-- Contacts Investor Relations: investorrelations@funko.com...
Acceleration of Initiatives to Address Market Trends Board of Directors Appointments Strengthen Leadership and Governance Management to Host Conference Call...
Contacts Investor Relations and Press Contacts: Stan Kovler Vice President, Corporate Strategy & Investor Relations Extreme Networks 919-595-4196 skovler@extremenetworks.com Amy...
Q1 Revenue of $21.7 million, up 17% year-over-year Q1 Ending ARR1 of $82.5 million, up 96% year-over-year Q1 Ending RPO2...
Company Reaffirms 2024 Outlook HOUSTON, May 9, 2024 /PRNewswire/ -- Drilling Tools International Corp., (NASDAQ: DTI) ("DTI" or the "Company"),...
Phase 2 MaGic trial in generalized Myasthenia Gravis (gMG) ongoing, with top-line results anticipated in 2H’25Building a neuromuscular franchise with...
MIAMI, FL / ACCESSWIRE / May 9, 2024 / Dolphin Entertainment (NASDAQ:DLPN), a leading entertainment marketing and premium content production...
Return to Seasonal Growth Expected in Second Quarter with First Quarter Representing the Low Point in Market Demand Contacts Company...
SEATTLE, May 09, 2024 (GLOBE NEWSWIRE) -- DoubleDown Interactive (NASDAQ: DDI) (“DoubleDown” or the “Company”), a leading developer and publisher...
First Quarter Revenue of $631.3 Million, up 3.3% year-over-year; on a constant currency basis, up 3.2% year-over-year GAAP Operating Margin...
Contacts Caliber: Victoria Rotondo +1 480-295-7600 Victoria.Rotondo@caliberco.com Investor Relations: Lisa Fortuna, Financial Profiles +1 310-622-8234 ir@caliberco.com Media Relations: Kelly McAndrew,...
PRINCETON, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a pioneer in critical care and cardiac surgery...
Third Quarter 2024 Revenue of $67.9 Million, Driven by 15.5% Year Over Year Growth in Subscription and Transaction Fees Third...
Late-Breaking Presentations of Initial Results From Phase 2 Studies of Atumelnant (CRN04894) in Congenital Adrenal Hyperplasia and ACTH-Dependent...
SHAKOPEE, Minn., May 09, 2024 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (Nasdaq: CPHC), today reported...
– Generated Q1’24 Net Revenue of $144.9 Million –– Delivered Q1’24 Record Belbuca® Revenue of $50.7 Million; Total Prescriptions Up...
SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company...
SOMERSET, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and...
HOFFMAN ESTATES, Ill., May 9, 2024 /PRNewswire/ -- Cambium Networks Corporation ("Cambium Networks") (NASDAQ: CMBM), a leading provider of wireless...
Contacts Media Contact: Gary Foster (949) 437-1113 Gary.Foster@cleanenergyfuels.com Investor Contact: Thomas Driscoll (949) 437-1191 Thomas.Driscoll@cleanenergyfuels.com Clean Energy Fuels Corp. (NASDAQ:...
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a U.S.-based Bitcoin...
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”), a U.S.-based Bitcoin...
AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Chuy’s Holdings, Inc. (NASDAQ:CHUY) (the "Company") today announced financial results for the...
– Net revenue of $77.1 million in Q1 2024 – – CRI and ENB Therapeutics development partnership for toripalimab in ovarian...
Raises 2024 Revenue Guidance to $274 to $282 Million Contacts CareDx, Inc. Media Relations Anna Czene 818-731-2203 aczene@caredx.com Investor Relations...
1Q’24 Marketplace Revenue and QARSD growth accelerated further to 12% YoY and 14% YoY, respectively1Q’24 Consolidated Net Income of $21.3...
Increased Total Orders by 13.7% and Repeat Orders by Over 20% Year-Over-YearIncreased First Quarter 2024 Gross Margin by 500 bps...
Bowie, MD, May 09, 2024 (GLOBE NEWSWIRE) -- Blink Charging Co. (Nasdaq: BLNK) (“Blink” or the “Company”), a leading manufacturer,...
Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP...
Continued Clinical and Regulatory Progress on the AIMIGo™ 3D VECG System Presented Positive Results on its Artificial Intelligence Capabilities for...
Contacts Investor Contact: ICR for Brightcove Brian Denyeau, 646-277-1251 brian.denyeau@icrinc.com Media Contact: Brightcove Sara Griggs, 929-888-4866 sgriggs@brightcove.com Brightcove Inc. (NASDAQ:...
First quarter SaaS revenue of $51.3 million, representing 44% year-over-year growthFirst quarter Total revenue of $74.5 million, representing 25% year-over-year...
Tab-cel® U.S. BLA on Track for Submission in Q2 2024 Initiation of ATA3219 Lupus Nephritis Study Expected in Q4 2024,...
- Conference Call and Webcast Today, May 9, 2024, at 4:30 p.m. ET Contacts Arrowhead Pharmaceuticals, Inc. Vince Anzalone, CFA...